Optical Markers in Duodenal Mucosa Predict the Presence of Pancreatic Cancer

Yang Liu(University of Illinois Urbana-Champaign), Vadim Backman(Unknown), Vladimir Turzhitsky(Northwestern University), Nahla Hasabou, Randall E. Brand(University of Pittsburgh), Charles D. Sturgis(Mayo Clinic), Young L. Kim(Purdue University West Lafayette), Hemant K. Roy(Mymensingh Medical College Hospital), Dhiren Shah(Northwestern University), Curtis R. Hall(Endeavor Health)
Clinical Cancer Research
August 1, 2007
10.1158/1078-0432.ccr-06-1648
Cited by 54

Related Papers

Detection and localization of surgically resectable cancers with a multi-analyte blood test
|Science|2018|2.8k
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k
Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium
|Gut|2019|620
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers
|Proceedings of the National Academy of Sciences|2017|577
A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts
|Gastroenterology|2015|472